Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Patrice Baillargeon

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|November 2, 2005
Use of insulin sensitizers in polycystic ovarian syndromeJean-Patrice Baillargeon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 29, 2007
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndromeClaudia Gagnon, Jean-Patrice Baillargeon
Fertility and Sterility|June 15, 2007
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivityJean-Patrice Baillargeon, André Carpentier
Fertility and Sterility|April 2, 2010
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practiceLysanne Pelletier, Jean-Patrice Baillargeon
Fertility and Sterility|July 27, 2010
Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndromeMarie-Hélène Pesant, Jean-Patrice Baillargeon
Nature Clinical Practice. Endocrinology & Metabolism|May 16, 2007
Ovulation induction in polycystic ovary syndrome-how do metformin and clomifene citrate compare?Marie-Hélène Pesant, Jean-Patrice Baillargeon
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?Jean-Patrice Baillargeon, John E Nestler
Current Diabetes Reports|November 16, 2014
PCOS in adolescence and type 2 diabetesAnne-Marie Carreau, Jean-Patrice Baillargeon
Environmental Science and Pollution Research International|May 9, 2025
Examining the relationship between persistent organic pollutants and metabolic-associated fatty liver disease: a cross-sectional analysis using NHANES dataCarlina Colussi, Jean-Patrice Baillargeon, Gérard Ngueta
Metabolic Syndrome and Related Disorders|March 25, 2017
Alanine Aminotransferase Is a Marker of Lipotoxicity Consequences and Hyperandrogenemia in Women with Polycystic Ovary SyndromeMatea Belan, Chloé Pelletier, Jean-Patrice Baillargeon
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|November 2, 2005
Use of insulin sensitizers in polycystic ovarian syndromeJean-Patrice Baillargeon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 29, 2007
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndromeClaudia Gagnon, Jean-Patrice Baillargeon
Fertility and Sterility|June 15, 2007
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivityJean-Patrice Baillargeon, André Carpentier
Fertility and Sterility|April 2, 2010
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practiceLysanne Pelletier, Jean-Patrice Baillargeon
Fertility and Sterility|July 27, 2010
Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndromeMarie-Hélène Pesant, Jean-Patrice Baillargeon
Nature Clinical Practice. Endocrinology & Metabolism|May 16, 2007
Ovulation induction in polycystic ovary syndrome-how do metformin and clomifene citrate compare?Marie-Hélène Pesant, Jean-Patrice Baillargeon
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?Jean-Patrice Baillargeon, John E Nestler
Current Diabetes Reports|November 16, 2014
PCOS in adolescence and type 2 diabetesAnne-Marie Carreau, Jean-Patrice Baillargeon
Environmental Science and Pollution Research International|May 9, 2025
Examining the relationship between persistent organic pollutants and metabolic-associated fatty liver disease: a cross-sectional analysis using NHANES dataCarlina Colussi, Jean-Patrice Baillargeon, Gérard Ngueta
Metabolic Syndrome and Related Disorders|March 25, 2017
Alanine Aminotransferase Is a Marker of Lipotoxicity Consequences and Hyperandrogenemia in Women with Polycystic Ovary SyndromeMatea Belan, Chloé Pelletier, Jean-Patrice Baillargeon
Pageof 11